Cargando…

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis

BACKGROUND AND OBJECTIVES: Myelin oligodendrocyte glycoprotein antibody–associated disorder (MOGAD) is a rare, autoimmune demyelinating CNS disorder, distinct from multiple sclerosis and neuromyelitis optica spectrum disorder. Characterized by pathogenic immunoglobulin G (IgG) antibodies against MOG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remlinger, Jana, Madarasz, Adrian, Guse, Kirsten, Hoepner, Robert, Bagnoud, Maud, Meli, Ivo, Feil, Moritz, Abegg, Mathias, Linington, Christopher, Shock, Anthony, Boroojerdi, Babak, Kiessling, Peter, Smith, Bryan, Enzmann, Volker, Chan, Andrew, Salmen, Anke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759074/ https://www.ncbi.nlm.nih.gov/pubmed/35027475 http://dx.doi.org/10.1212/NXI.0000000000001134

Ejemplares similares

Modeling MOG Antibody–Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations
por: Remlinger, Jana, et al.
Publicado: (2023)

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis
por: Bagnoud, Maud, et al.
Publicado: (2020)

In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling
por: Bagnoud, Maud, et al.
Publicado: (2023)

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
por: Schmid, Rahel Dominique, et al.
Publicado: (2022)

Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort
por: Veselaj, Krenar, et al.
Publicado: (2020)

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses
por: Gili-Kovács, Judit, et al.
Publicado: (2021)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
por: Briner, Myriam, et al.
Publicado: (2019)

MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated
por: Flytzani, Sevasti, et al.
Publicado: (2015)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer
por: Rajaratinam, Harishini, et al.
Publicado: (2021)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells
por: Guse, Kirsten, et al.
Publicado: (2022)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Retinal layer segmentation in a cohort of healthy children via optical coherence tomography
por: Runge, Anna-Katharina, et al.
Publicado: (2022)

A Brief Review of the Effects of Vitamin D on Multiple Sclerosis
por: Miclea, Andrei, et al.
Publicado: (2020)

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
por: Thiele née Schrewe, Lisa, et al.
Publicado: (2020)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
por: das Neves, Sofia P., et al.
Publicado: (2018)

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis
por: Hoepner, Robert, et al.
Publicado: (2019)

AZD-1222: Acute disseminated encephalomyelitis anti-MOG antibody‑positive: case report
Publicado: (2022)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
por: Dong, Xueshan, et al.
Publicado: (2023)

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells
por: Mannara, Francesco, et al.
Publicado: (2012)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
por: Kim, Ji-Youn, et al.
Publicado: (2020)

Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis
por: Cai, Yuanhua, et al.
Publicado: (2022)

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data
por: Salmen, Anke, et al.
Publicado: (2023)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
por: Zoehner, Greta, et al.
Publicado: (2019)

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide
por: Buerth, Christoph, et al.
Publicado: (2016)

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
por: Derdelinckx, Judith, et al.
Publicado: (2019)

Characterization of myelin oligodendrocyte glycoprotein (MOG)(35–55)-specific CD8(+) T cells in experimental autoimmune encephalomyelitis
por: Peng, Yong, et al.
Publicado: (2019)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
por: Otiv, Madhumati, et al.
Publicado: (2022)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells
por: Gong, Yeli, et al.
Publicado: (2012)

MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation
por: Loos, Julia, et al.
Publicado: (2020)

Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis
por: Shen, Weibing, et al.
Publicado: (2021)

Arg Deficiency Does not Influence the Course of Myelin Oligodendrocyte Glycoprotein (MOG35-55)-induced Experimental Autoimmune Encephalomyelitis
por: Jacobsen, Freja Aksel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bmdfje590nu992m4vqccmrd2un